Asthma outcome measures

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 11, Issue 4, 2011, Pages 447-453

  Shen, Joannie ^a   Johnston, Michael ^b   Hays, Ron D ^b  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

asthma control; asthma exacerbation; asthma outcomes; asthma self management; health related quality of life

Indexed keywords

ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; BRONCHODILATING AGENT; CORTICOSTEROID;

ASTHMA; BEHAVIOR MODIFICATION; CLINICAL EFFECTIVENESS; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; HUMAN; INSTRUMENT VALIDATION; LUNG FUNCTION TEST; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; QUALITY ADJUSTED LIFE YEAR; REVIEW; SYMPTOM;

ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; UNITED STATES;

EID: 80051729062     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.11.48     Document Type: Review

References (70)

1. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart Lung and Blood Institute, Bethesda, MD, USA (2007).
2. Reddel H, Taylor R, Bateman E et al. An Official American Thoracic Society/ European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am. J. Repir. Crit. Care Med. 180, 59-99 (2009).
3. Tarrant MA, Manfredo MJ, Bayley PB, Hess R. Effects of recall bias and nonresponse bias on self-report estimates of angling participation. North Am. J. Fisheries Management 13, 217-222 (1993).
4. McLeod LD, Coon CD, Martin S, Fehnel SE, Hays RD. Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev. Pharmacoeconomics Outcomes Res. 11(2), 163-169 (2011).
5. National Asthma Education and Prevention Program Expert Panel Report: 2. Guidelines for the Diagnosis and Management of Asthma, National Heart Lung and Blood Institute, Bethesda, MD, USA (1997).
6. Taylor DR, Bateman ED, Boulet L-P et al. A new perspective on concepts of asthma severity and control. Eur. Respir. J. 32, 545-554 (2008).
7. Woolcock A, Rubinfeld AR, Seale JP et al. Thoracic Society of Australia and New Zealand. Asthma management plan. Med. J. Aust. 151, 650-653 (1989).
8. National Heart Lung and Blood Institute. International consensus report on diagnosis and treatment of asthma. Eur. Respir. J. 5, 601-641 (1992).
9. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am. J. Respir. Crit. Care Med. 157, 4-9 (1998). (Pubitemid 28071253)
10. Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness and airway function in asthma: results of a factor analysis. J. Allergy Clin. Immunol. 103, 232-237 (1999 (Pubitemid 29095827)
11. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 14, 902-907 (1999). (Pubitemid 29519356)
12. Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest 114(4), 998-1007 (1998). (Pubitemid 28495893)
13. Li JTC, O'Connell EJ. Clinical evaluation of asthma. Ann. Allergy Asthma Immunol. 76(1), 1-14 (1996).
14. Pinnock H, Fletcher M, Holmes S et al. Setting the standard for routine asthma consultations: a discussion of the aims, process and outcomes of reviewing people with asthma in primary care. Prim. Care Respir. J. 19(1), 75-83 (2010).
15. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am. Rev. Respir. Dis. 147, 832-838 (1993). (Pubitemid 23093803)
16. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur. Respir. J. 10, 646-651 (1997). (Pubitemid 27112583)
17. Hays RD, Reeve BB. Measurement and modeling of health-related quality of life. In:Epidemiology and Demography in Public Health. Killewo J, Heggenhougen HK, Quah SR (Eds). Elsevier, Oxford, UK, 195-205 (2010).
18. Ford ES, Mannino DM, Redd SC, Moriarty DG, Mokdad AH. Determinants of quality of life among people with asthma: findings from the Behavioral Risk Factor Surveillance System. J. Asthma 41, 327-336 (2004). (Pubitemid 38823315)
19. Smith AW, Reeve BB, Bellizzi KM et al. Cancer, comorbidities and health-related quality of life of older adults. Health Care Financ. Rev. 29(4), 41-56 (2008).
20. Escorpizo R, Bombardier C, Boonen A et al. Worker productivity outcome measures in arthritis. J. Rheumatol. 34(6), 1372-1380 (2007). (Pubitemid 46898124)
21. Mattke S, Balakrishnan A, Bergamo G, Newberry SJ. A review of methods to measure health-related productivity loss. Am. J. Manag. Care 3(4), 211-217 (2007). (Pubitemid 46608585)
22. Prasad M, Wahlqvist P, Shikiar R, Shih YC. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics 22(4), 225-244 (2004). (Pubitemid 38393392)
23. Lofland JH, Pizzi L, Frick KD. A review of health-related workplace productivity loss instruments. Pharmacoeconomics 22(3), 165-184 (2004). (Pubitemid 38333649)
24. Lerner DJ, Amick BC III, Rogers WH, Malspeis S, Bungay K. The work limitations questionnaire: a self-administered instrument for assessing on-the-job work disability. Med. Care 39(1), 72-85 (2001).
25. Kessler RC, Ames M, Hymel PA et al. Using the WHO health and work performance questionnaire (HPQ) to evaluate the indirect workplace costs of illness. J. Occup. Environ. Med. 46(Suppl. 6), S23-S37 (2004). (Pubitemid 38747691)
26. Kessler RC, Barber C, Beck AL et al. The World Health Organization health and work performance questionnaire (HPQ). J. Occup. Environ. Med. 45(2), 156-174 (2003). (Pubitemid 36228294)
27. Schultz AB, Edington DW. Employee health and presenteeism: a systematic review. J. Occup. Rehabil. 17(3), 547-579 (2007).
28. Chen H, Blanc PD, Hayden ML et al. Assessing productivity loss and activity impairment in severe or difficult to treat asthma. Value Health 11, 231-239 (2008). (Pubitemid 351473606)
29. Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J. Clin. Epidemiol. 45, 461-472 (1992).
30. Marks GB, Dunn SM, Woolcock AJ. An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma. J. Clin. Epidemiol. 46, 1103-1111 (1993). (Pubitemid 23302077)
31. Meads DM, McKenna SP, Doward LC et al. Development and validation of the Asthma Life Impact Scale (ALIS). Respir. Med. 104, 633-643 (2010).
32. Turner-Bowker DM, Saris-Baglama RN, DeRosa MA, Paulsen CA. Development of a dynamic assessment for asthma impact: incorporating consumer and asthma specialist feedback. Ann. Behav. Med. 37(Suppl. B-141) (2009).
33. Kaplan RM, Sieber WJ, Ganiats TG. The quality of well-being scale: comparison of the interviewer-administered version with a self-administered questionnaire. Psychol. Health 12, 783-791 (1997). (Pubitemid 127538602)
34. Feeny D, Furlong W, Torrance GW et al. Multi-attribute and single attribute utility functions for the Health Utilities Index Mark 3 System. Med. Care 40, 113-128 (2002).
35. Brooks R, Rabin R, de Charro F. The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective. Kluwer Academic Publishers, Dordrecht, The Netherlands (2003).
36. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med. Care 42, 851-859 (2004). (Pubitemid 39456916)
37. Kaplan RM, Tally S, Hays RD et al. Five preference-based indexes in cataract and heart failure patients were not equally responsive to change. J. Clin. Epidemiol. 64, 497-506 (2010).
38. Institute of Medicine (IOM).Valuing Health for Regulatory Cost-Effectiveness Analysis. Miller W, Robinson LA, Lawrence RS (Eds). Committee to evaluate measures of health benefits for environmental, health and safety regulation. National Academy Press, Washington, DC, USA (2006).
39. Jenkins CR, Thien FCK, Wheatley JR, Reddel HK. Traditional and patient-centred outcomes with three classes of asthma medication. Eur. Respir. J. 26, 36-44 (2005). (Pubitemid 40945929)
40. Osborne ML, Pedula KL, O'Hollaren M et al. Assessing future need for acute care in adult asthmatics: the profile of asthma risk study: a prospective health maintenance organization-based study. Chest 132, 1151-1161 (2007). (Pubitemid 47620987)
41. Ulrik CS, Frederiksen J. Mortality and markers of risk of asthma death among 1,075 outpatients with asthma. Chest 108, 10-15 (1995).
42. Fuhlbrigge AL, Weiss ST, Kuntz KM, Paltiel AD. CAMP Research Group. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma. Pediatrics 118, E347-E355 (2006). (Pubitemid 46085375)
43. Szefler SJ, Martin RJ, King TS et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J. Allergy Clin. Immunol. 109, 410-418 (2002). (Pubitemid 34234189)
44. Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness and airway function in asthma: results of a factor analysis. J. Allergy Clin. Immunol. 103, 232-237 (1999 (Pubitemid 29095827)
45. Jenkins CR, Thien FCK, Wheatley JR, Reddel HK. Traditional and patient-centred outcomes with three classes of asthma medication. Eur. Respir. J. 26, 36-44 (2005). (Pubitemid 40945929)
46. Schatz M, Mosen D, Apter AJ et al. Relationships among quality of life, severity and control measures in asthma: an evaluation using factor analysis. J. Allergy Clin. Immunol. 115, 1049-1055 (2005). (Pubitemid 40616222)
47. Shingo S, Zhang J, Reiss TF. Correlation of airway obstruction and patient-reported endpoints in clinical studies. Eur. Respir. J. 17, 220-224 (2001). (Pubitemid 32600581)
48. Moy ML, Israel E, Weiss ST, Juniper EF, Dube L, Drazen JM. Asthma Clinical Research Network. Clinical predictors of health-related quality of life depend on asthma severity. Am. J. Respir. Crit. Care Med. 163, 924-929 (2001). (Pubitemid 32275865)
49. Juniper EF, O'Byrne PM, Roberts JN. Measuring asthma control in group studies: do we need airway calibre and rescue b2-agonist use? Respir. Med. 95, 319-323 (2001). (Pubitemid 32624474)
50. Lim S, Jatakanon A, John M et al. Effect of inhaled budesonide on lung function and airway inflammation: assessment by various inflammatory markers in mild asthma. Am. J. Respir. Crit. Care Med. 159, 22-30 (1999). (Pubitemid 29036498)
51. Booth H, Richmond I, Ward C, Gardiner PV, Harkawat R, Walters EH. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 152, 45-52 (1995).
52. Fuhlbrigge AL. Asthma severity and asthma control: symptoms, pulmonary function and inflammatory markers. Curr. Opin. Pulm. Med. 10, 1-6 (2004). (Pubitemid 38045894)
53. Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness and airway function in asthma: results of a factor analysis. J. Allergy Clin. Immunol. 103, 232-237 (1999). (Pubitemid 29095827)
54. O'Byrne PM, Inman MD. Airway hyperresponsiveness. Chest 123, 411S-416S (2003). (Pubitemid 36315439)
55. Leuppi JD, Salome CM, Jenkins CR et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 163, 406-412 (2001). (Pubitemid 32158520)
56. Rasmussen F, Taylor DR, Flannery EM et al. Risk factors for hospital admission for asthma from childhood to young adulthood: a longitudinal population study. J. Allergy Clin. Immunol. 110(2), 220-227 (2002).
57. Grol MH, Gerritsen J, Vonk JM et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years: a 30-year follow-up study. Am. J. Respir. Crit. Care Med. 160, 1830-1837 (1999). (Pubitemid 30004683)
58. O'Connor GT, Sparrow D, Weiss ST. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary function decline, the Normative Aging Study. Am. J. Respir. Crit. Care Med. 152, 87-92 (1995).
59. Brutsche MH, Downs SH, Schindler C et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals. SAPALDIA cohort study. Thorax 61, 671-677 (2006). (Pubitemid 44211773)
60. Nuijsink M, Hop WCJ, Sterk PJ, Duiverman EJ, de Jongste JC. Long-term asthma treatment guided by airway hyperresponsiveness in children, a randomised controlled trial. Eur. Respir. 30, 457-466 (2007). (Pubitemid 351182068)
61. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. The AMPUL Study Group. Clinical control and histopathologic outcome of asthma when using airway hyperresponsivenessas an additional guide to long-termtreatment. Am. J. Respir. Crit. Care Med. 159, 1043-1051 (1999). (Pubitemid 29202534)
62. Cox G, Miller JD, McWilliams A, Fitzgerald JM, Lam S. Bronchial thermoplasty for asthma. Am. J. Respir. Crit. Care Med. 173, 965-969 (2006).
63. Osborne ML, Pedula KL, O'Hollaren M et al. Assessing future need for acute care in adult asthmatics, the profile of asthma risk (PAR) study. A prospective health maintenance organization-based study. Chest 132, 1151-1161 (2007). (Pubitemid 47620987)
64. Green RH, Brightling CE, McKenna S et al. Asthma exacerbations and sputum eosinophil counts, a randomized controlled trial. Lancet 360, 1715-1721 (2002). (Pubitemid 35447900)
65. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N. Engl. J. Med. 352, 2163-2173 (2005).
66. Lahdensuo A, Haahtela T, Herrala J et al. Randomised comparison of guided self management and traditional treatment of asthma over one year. BMJ 312, 748-752 (1996). (Pubitemid 26091240)
67. Gibson PG, Powell H, Coughlan J et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst. Rev. 1, CD001117 (2003).
68. Mancuso CA, Sayles W, Allegrante JP. Development and testing of the Asthma self-management questionnaire. Ann. Allergy Asthma Immunol. 102, 294-302 (2009).
69. CDC Vital Signs - Asthma in the US www.cdc.gov/VitalSigns/Asthma
70. Global Initiative for Asthma. Global strategy for asthma management and prevention 2008 www.ginasthma.org (Accessed 8 August 2010)